Bryan C. Batch

Bryan C. Batch

Auto-generated profile, based on publicly available information

Bryan C. Batch

Associate Editor, Annals of Internal Medicine, Philadelphia, Pennsylvania, and Division of Endocrinology, Department of Medicine, Duke University, Durham, North Carolina (B.C.B.)

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2013 in Metabolism
Verified
Journal Article
Closed access
BBBryan C. Batch
Bryan C. Batch
SSSvati H. Shah
Svati H. Shah
CNChristopher B. Newgard
Christopher B. Newgard
CTChristy B. Turer
Christy B. Turer
CHCarol Haynes
Carol Haynes
LSLaura P. Svetkey
Laura P. Svetkey

1 May 2016 in Contemporary Clinical Trials
Verified
Journal Article
Closed access
PFPerry Foley
Perry Foley
DSDori Steinberg
Dori Steinberg
ELErica Levine
Erica Levine
SASandy Askew
Sandy Askew
BBBryan C. Batch
Bryan C. Batch
GBGary G. Bennett
Gary G. Bennett

1 December 2011 in Journal of the American Dietetic Association
Verified
Journal Article
Closed access
CCCatherine Champagne
Catherine Champagne
Stephanie BroylesStephanie Broyles
Stephanie Broyles
LMLaura D. Moran
Laura D. Moran
KCKatherine C. Cash
Katherine C. Cash
ELErma J. Levy
Erma J. Levy
VMValerie H. Myers
Valerie H. Myers

26 February 2019 in Current Diabetes Reports
Verified
Journal Article
Closed access
PDF file
AAAnastasia-Stefania Alexopoulos
Anastasia-Stefania Alexopoulos
AQAli Qamar
Ali Qamar
KHKathryn Hutchins
Kathryn Hutchins
MCMatthew J. Crowley
Matthew J. Crowley
BBBryan C. Batch
Bryan C. Batch
JGJohn R. Guyton
John R. Guyton

20 January 2021 in Journal of Medical Internet Research
Verified
Journal Article
Open access
BBBryan C Batch
Bryan C Batch
SSSusan E Spratt
Susan E Spratt
DBDan V Blalock
Dan V Blalock
CBChad Benditz
Chad Benditz
AWAndi Weiss
Andi Weiss
ACAlex H Cho
Alex H Cho
Background: Type 2 diabetes affects 30 million Americans, representing a significant cause of morbidity and mortality. Self-management support is an important component of chronic illness care and is a key pillar of the chronic care model. Face-to-face teaching and patient education materials suffer from being static or incompatible with mobile lifestyles. Digital apps provide a self-management support alternative that is convenient and scalable. Objective: This pilot study tested the real-world deployment of a self-guided mobile app for diabetes education (Time2Focus app; MicroMass Communications Inc, Cary, NC), which utilizes evidence-based content and gamification to deliver an interactive learning experience. Methods: Primary care providers were approached for permission to invite their patients to participate. Eligible patients were 18 to 89 years of age, had a diagnosis of type 2 diabetes, hemoglobin A1c (HbA1c) ≥8% and <12% in the past 3 months, an active online patient portal account (tied to the electronic health record), and access to an iOS or Android smartphone. Interested patients were emailed a baseline survey, and once this was completed, were sent instructions for downloading the Time2Focus app. After completing all 12 levels, participants were sent a follow-up survey. The primary outcome was the change in HbA1c. Secondary outcomes included medication adherence, self-care activities, self-reporting of physical activities, diabetes self-efficacy, illness perceptions, diabetes distress scale, and users’ engagement with and rating of the app. Results: Of 1355 potentially eligible patients screened, 201 were consented. Of these 201 patients, 101 (50.2%) did not download the app. Of the 100 participants (49.8%) who downloaded the app, 16 (16.0%) completed 0 levels, 26 (26.0%) completed 1 to 4 levels, 10 (10.0%) completed 5 to 11 levels, and 48 (48.0%) completed all 12 levels of the app and the follow-up survey. Those completing one or more levels had a mean pre/post-HbA1c change of –0.41% (compared to –0.32% among those who completed zero levels); however, the unadjusted two-tailed t test indicated no significant difference between the two groups (P=.73). Diabetes self-efficacy showed a large and significant increase during app usage for completers (mean change 1.28, P<.001, d=.83). Severity of illness perceptions showed a small but significant decrease during app usage for completers (mean change –0.51, P=.004, d=.43). Diabetes distress showed a small but significant decrease during app usage for completers (mean change –0.45, P=.006, d=.41). The net promoter score was 62.5, indicating that those who completed all levels of the app rated it highly and would recommend it to others. Conclusions: Participants who engaged in all 12 levels of the Time2Focus mobile app showed an improvement in diabetes self-efficacy and a decrease in severity of illness perceptions. The decrease in HbA1c observed in app users relative to nonusers during this limited pilot study was not statistically significant. However, uptake and application of lessons learned from self-management support may be delayed. Further research is needed to address how to increase engagement through self-management support and to investigate if follow up over a longer period demonstrates a significant change in outcomes such as HbA1c.

18 October 2018 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
PLPao-Hwa Lin
Pao-Hwa Lin
SGSteven Grambow
Steven Grambow
SIStephen Intille
Stephen Intille
JGJohn A Gallis
John A Gallis
TLTony Lazenka
Tony Lazenka
LSLaura Svetkey
Laura Svetkey
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Mobile health (mHealth) technology provides innovative ways to deliver weight loss interventions. Understanding how engagement in mHealth interventions relates to weight change may help develop more effective intervention strategies. Objective: To examine 1) patterns of participant engagement overall and in key intervention features within the interventions of the Cell Phone Intervention For You (CITY) clinical trial, 2) associations of engagement with weight change, and 3) characteristics of participants that are related to engagement. Methods: The CITY trial tested two 24-month behavioral weight loss interventions. One was delivered with a smartphone application (app) (Cell Phone; CP) that contained 24 features (weighing, tracking of diets, etc.) and included regular prompting by the app in pre-determined frequency and forms. The other intervention was delivered by a coach via monthly phone calls (Personal Coaching; PC) supplemented with limited app features (18 total) and without any prompting by the app. Engagement was assessed by calculating the percentage of days each app feature was used and the frequency of usage. Engagement was also examined across four weight change categories: gained (≥2%), stable (±2%), mild loss (≥2% to <5%), and greater loss (≥5%). Results: Data from 122 CP and 120 PC participants were analyzed. Usage of the app features was highest during month 1 for both groups; thereafter, usage dropped substantially and continuously until the end of the study. During the first six months, mean percentage of days any app feature was used was higher for the CP (74.2%, standard deviation [SD], 20.1) than for the PC group (48.9%, SD, 22.4). The CP group used the app features an average of 5.3 times/day [SD, 3.1], while the PC used them 1.7 times/day [SD, 1.2]. Similarly, when the self-weighing feature was examined alone, CP self-weighed more than PC (57.1% days [SD, 23.7] vs. 32.9% [23.3]). Further, percentage of days any app feature was used, number of app usages/day and percentage of days self-weighed all showed significant differences across the four weight categories for both CP and PC. Pearson correlation coefficients showed a negative linear association between weight change and percentage of days any app feature was used (CP: r=-0.213; PC: r=-0.319), number of app usages/day (CP:r=-0.264; PC:r=-0.308), and percentage of days self-weighed (CP:r=-0.297; PC:r=-0.354). Conclusions: Engagement in CITY intervention was associated with weight loss during the first six months. Nevertheless, engagement dropped substantially early on for most intervention features. Prompting may be helpful initially. More flexible and less-intrusive prompting strategies may be needed during different stages of an intervention to increase or sustain engagement. Future studies should explore the motivations for engagement and non-engagement in order to design effective intervention. Clinical Trial: NCT01092364